Filer Snapshot

Oleg Nodelman

CIK 0001454385. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Individual

Total filings

6

Latest filing

22 Sep 2023

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13D/G stake for Aktis Oncology, Inc.. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open 13D/G history Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

Aktis Oncology, Inc.

12 Jan 2026 · 9.1% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Forms 3/4/5

4/A filed on 22 Sep 2023 for CIK 0001454385.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

Forms 3/4/5 positions$235.36M

Reporting-owner positions with enough filing detail to estimate value.

Forms 3/4/5 position value

3/4/5
$235.36M

Estimated from parsed Forms 3/4/5 when filings include enough share and price data.

Source: Forms 3/4/5Confidence: Estimated when price data is available

Largest linked holdings

Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.

ZYME NUVB
How to read these SEC ownership signals
  • Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
  • Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
  • Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
357 Tehama Street #3, San Francisco, CA, 94103

Filer intelligence

What SEC filings say about Oleg Nodelman

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • 1 recent 13D/G stake row found; top row is Aktis Oncology, Inc. at 9.1% ownership.
  • Forms 3/4/5 show insider context for ZYME worth $218.11M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes 1 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 2 rows

Officer, director, and 10% owner holdings or transactions.

Open

13D/G large-stake context

Aktis Oncology, Inc.

12 Jan 2026 · Common Stock

9.1%
Issuer page 13D/G history

Forms 3/4/5 insider context

ZYME

17 Feb 2025 · 10% owner

$218.11M
Issuer page Owner page

NUVB

19 Sep 2023

$17.25M
Issuer page Owner page

Latest update

What changed recently for Oleg Nodelman

Ownership report updated

Latest ownership report period: 17 Feb 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

18 Feb 2025

Page type

Ownership filings

Latest period

17 Feb 2025

Ownership context was refreshed from SEC Forms 3/4/5 filed on 18 Feb 2025.

Open ownership filings Browse recent public updates

SEC filing record

CIK 0001454385 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
6
First seen
17 Feb 2015
Latest filing
22 Sep 2023
Entity
Individual

Observed form types

13F-NT 4 4/A

CIK-linked evidence first

Oleg Nodelman SEC filings Oleg Nodelman 13F portfolio Oleg Nodelman 13D/G history Oleg Nodelman owner filings Open SEC filing index

Latest Filings

Showing the latest 6 of 6 SEC filings for Oleg Nodelman.

4/A

4/A filing

Filing date
22 Sep 2023
Reporting date
19 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Sep 2023
Reporting date
19 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 May 2023
Reporting date
28 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Nov 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Nov 2021
Reporting date
29 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-NT

13F-NT filing

Filing date
17 Feb 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .